These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 490841)

  • 1. Moderate-dose radiotherapy for glottic cancer.
    JAMA; 1979 Nov; 242(22):2382. PubMed ID: 490841
    [No Abstract]   [Full Text] [Related]  

  • 2. Definitive radiation management for carcinoma of the glottic larynx.
    Moose BD; Greven KM
    Otolaryngol Clin North Am; 1997 Feb; 30(1):131-43. PubMed ID: 8995141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dose-time-volume factors in radiotherapy of T2N0M0 glottic cancer].
    Kagami Y; Nishiyama K; Ikeda H; Masaki N; Shigematsu Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Oct; 43(10):1194-8. PubMed ID: 6672748
    [No Abstract]   [Full Text] [Related]  

  • 4. Health-related quality of life and voice following radiotherapy for laryngeal cancer--a comparison between glottic and supraglottic tumours.
    Tuomi L; Karlsson T; Johansson M; Finizia C
    Acta Oncol; 2015 Jan; 54(1):73-9. PubMed ID: 24914482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation therapy for glottic cancer using 6-MV photons.
    Beitler JJ; Yaes RJ; Lai PP; Vikram B
    Cancer; 1996 Jul; 78(1):183-4. PubMed ID: 8646719
    [No Abstract]   [Full Text] [Related]  

  • 6. Higher laryngeal preservation rate after CO2 laser surgery compared with radiotherapy in T1a glottic laryngeal carcinoma.
    Schrijvers ML; van Riel EL; Langendijk JA; Dikkers FG; Schuuring E; van der Wal JE; van der Laan BF
    Head Neck; 2009 Jun; 31(6):759-64. PubMed ID: 19260127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of underdosage in the external photon beam radiotherapy of glottic carcinoma: Monte Carlo study.
    Spirydovich S; Papiez L; Moskvin V; Desrosiers P
    Radiother Oncol; 2006 Feb; 78(2):159-64. PubMed ID: 16360226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of overall time and dose on the response of glottic carcinoma of the larynx to radiotherapy.
    Fowler JF; Chappell R
    Eur J Cancer; 1994; 30A(5):719-21. PubMed ID: 8080696
    [No Abstract]   [Full Text] [Related]  

  • 9. Electron beam treatment of early glottic lesions.
    Soni SC; Khan FR; Ovadia J; Nickson JJ
    J Radiol Electrol Med Nucl; 1974; 55(6-7):481-3. PubMed ID: 4214457
    [No Abstract]   [Full Text] [Related]  

  • 10. [Relation between overall treatment time and local control of early glottic laryngeal cancer: comparison of six versus five times per week].
    Kitano M; Nishiguchi I; Aoki Y; Nakayama M; Nagai H; Takahashi H; Okamoto M; Matsubayashi T; Hayakawa K
    Nihon Igaku Hoshasen Gakkai Zasshi; 2002 Jun; 62(7):366-9. PubMed ID: 12136637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofractionated radiotherapy for T1N0M0 glottic cancer: retrospective analysis of two different cohorts of dose-fractionation schedules from a single institution.
    Laskar SG; Baijal G; Murthy V; Chilukuri S; Budrukkar A; Gupta T; Agarwal JP
    Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e180-6. PubMed ID: 22862908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated plasma CEA during radiotherapy for glottic carcinoma of the larynx.
    Jakobsson PA; Wahren B
    Can J Otolaryngol; 1975; 4(1):46-50. PubMed ID: 1131725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of the treatment of laryngeal cancer by a conventional method].
    Betkowski A; Szuber K; Wewiórska T; Małek J; Rudowska B
    Otolaryngol Pol; 1990; 44(6):384-7. PubMed ID: 2084602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [T1a glottic neoplasms: experience with surgery and radiotherapy].
    Nicolai P; Bovarini M; Bonfioli F; Bonetti B; Moretti R; Magno L; Antonelli AR
    Acta Otorhinolaryngol Ital; 1988; 8(6):581-90. PubMed ID: 3247844
    [No Abstract]   [Full Text] [Related]  

  • 15. Dosimetric and radiobiologic comparison of 3D conformal, IMRT, VMAT and proton therapy for the treatment of early-stage glottic cancer.
    Matthiesen C; Herman Tde L; Singh H; Mascia A; Confer M; Simpson H; Higby C; Arain A; Keole S; Herman T; Bogardus C; Zhao YD; Ahmad S
    J Med Imaging Radiat Oncol; 2015 Apr; 59(2):221-8. PubMed ID: 25146003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy for carcinoma of the supraglottis.
    Mendenhall WM; Parsons JT; Stringer SP; Cassisi NJ
    Otolaryngol Clin North Am; 1997 Feb; 30(1):145-61. PubMed ID: 8995142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radiation therapy in glottic laryngeal carcinoma stage. I. Results and analysis of prognostic factors].
    Skołyszewski J; Reinfuss M; Kowalska T; Walasek T; Dymek P
    Otolaryngol Pol; 1996; 50(3):243-7. PubMed ID: 9045160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tumor response and local control after radiation therapy of T1N0M0 glottic carcinoma].
    Inoue T; Inoue T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Dec; 43(12):1376-81. PubMed ID: 6674929
    [No Abstract]   [Full Text] [Related]  

  • 19. Irradiated volume and arytenoid edema after radiotherapy for T1 glottic carcinoma.
    Inoue T; Inoue T; Chatani M; Teshima T
    Strahlenther Onkol; 1992 Jan; 168(1):23-6. PubMed ID: 1734586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late local recurrence after radiotherapy for tongue and early glottic carcinoma.
    Inoue T; Inoue T; Teshima T; Murayama S; Nose T; Tanaka E; Yamazaki H; Koizumi M; Kagawa K; Ozeki S; Ikeda H
    Strahlenther Onkol; 1996 Jun; 172(6):301-5. PubMed ID: 8677501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.